Invesco
TIL icon

Invesco’s Instil Bio TIL Stock Holding History

Invesco’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-145,118
Closed -$9.77M – 3811
2024
Q3 		$9.77M Buy
+145,118
New +$3.42M ﹤0.01% 1853
2023
Q2 		– Sell
-955
Closed -$12.6K – 3944
2023
Q1 		$12.6K Sell
955
-81
-8% -$1.2K ﹤0.01% 3834
2022
Q4 		$13.1K Sell
1,036
-10
-1% -$494 ﹤0.01% 3993
2022
Q3 		$101K Sell
1,046
-9
-0.9% -$1.03K ﹤0.01% 3836
2022
Q2 		$97K Sell
1,055
-113
-10% -$16K ﹤0.01% 3891
2022
Q1 		$251K Buy
1,168
+56
+5% +$13.1K ﹤0.01% 3712
2021
Q4 		$381K Buy
+1,112
New +$429K ﹤0.01% 3505

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco's TIL Position: Q4 2024 in Review

Invesco sold out of Instil Bio (TIL) in Q4 2024, closing a stake of 145,118 shares — an estimated $9.77M sold.

Invesco first reported a position in TIL in Q4 2021 and held it in 7 quarters. The position peaked at $9.77M in Q3 2024. 40 funds tracked by Wall St. Rank hold TIL as of Q4 2024.

  • Invesco reported no remaining Instil Bio position as of Q4 2024 after selling out during the quarter.
  • Invesco sold 145,118 Instil Bio shares in Q4 2024, an estimated $9.77M.
  • Invesco first reported a position in Instil Bio in Q4 2021 and held it in 7 quarters.
  • Invesco's Instil Bio position peaked at $9.77M in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Instil Bio as of Q4 2024.

Based on Invesco's 13F filing for Q4 2024, filed 13 Feb 2025.